For patients who are uninsured and underinsured who meet certain eligibility criteria, Otsuka America Pharmaceutical, Inc. (OAPI), will provide Abilify Maintena free of charge to eligible patients. This program covers both Abilify Maintena and Abilify Maintena for Extended-Release Injectable Suspension.

How to Apply

Please either download the application below (if available) or go to the program website for more information on how to apply. Once you fill out your application, send it to the address on the application. Remember not to send program applications to PPA.

Product(s) Covered by Program

  • A

    • Abilify Maintena® (aripiprazole)